Nociceptin receptor Polyclonal Antibody, PE-Cy5 Conjugated
Referencia bs-0181R-PE-Cy5
embalaje : 100ul
Marca : Bioss
Nociceptin receptor Polyclonal Antibody, PE-Cy5 Conjugated
Applications
Reactivity
Predicted Reactivity
Overview | |
Catalog # | bs-0181r-pe-cy5-100ul |
Product Name | Nociceptin receptor Polyclonal Antibody, PE-Cy5 Conjugated |
Applications | WB |
Reactivity | Human, Mouse, Rat |
Predicted Reactivity | Dog, Cow, Pig, Horse, Guinea Pig |
Specifications | |
Conjugation | PE-Cy5 |
Host | Rabbit |
Source | KLH conjugated synthetic peptide derived from mouse Nociceptin receptor |
Immunogen Range | 1-47/370 |
Clonality | Polyclonal |
Isotype | IgG |
Concentration | 1ug/ul |
Purification | Purified by Protein A. |
Storage Buffer | Aqueous buffered solution containing 0.01M TBS (pH7.4) with 1% BSA, 0.02% Proclin300 and 50% Glycerol. |
Storage Condition | Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles. |
Target | |
Gene ID | 18389 |
Swiss Prot | P35377 |
Subcellular location | Cell membrane |
Synonyms | KOR3; ORGC; ORL1; Oprl; XOR1; morc; KOR-3; LC132; MOR-C; Nociceptin receptor; K3 opiate receptor; Kappa-type 3 opioid receptor; Orphanin FQ receptor; Oprl1; Oor |
Background | G-protein coupled opioid receptor that functions as receptor for the endogenous neuropeptide nociceptin. Ligand binding causes a conformation change that triggers signaling via guanine nucleotide-binding proteins (G proteins) and modulates the activity of down-stream effectors. Signaling via G proteins mediates inhibition of adenylate cyclase activity and calcium channel activity. Arrestins modulate signaling via G proteins and mediate the activation of alternative signaling pathways that lead to the activation of MAP kinases. Plays a role in modulating nociception and the perception of pain. Plays a role in the regulation of locomotor activity by the neuropeptide nociceptin. |
Application Dilution | |
WB | 1:300-5000 |